Moreover, especially the CD4+/CD8+ ratio may be used as an important marker for assessing the individual risk of severe COVID-19 in PLWH and to determine a suitable vaccination strategy for individuals with inadequate responses to antiviral therapy. The gene discussed is CD4; the disease is COVID-19.